Literature DB >> 8769299

Substance P--an underlying factor for pouchitis? Prospective study of substance P- and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells.

U Keränen1, H Järvinen, P Kärkkäinen, T Kiviluoto, E Kivilaakso, S Soinila.   

Abstract

Recent studies suggest that substance P (SP), vasoactive intestinal polypeptide (VIP), and mast cells play a role in inflammatory processes of the bowel. The aim of this study was to evaluate the distribution of SP and VIP immunoreactivities and to count mast cells in the ileal pouch of patients, who had pouchitis after restorative proctocolectomy performed for treatment of ulcerative colitis (UC), and to compare the findings in the same patients after a follow-up period. Nine patients with pouchitis underwent clinical evaluation, endoscopy of the pouch, and histological examination, which were repeated after the follow-up period of 14 months on average. The number and intensity of SP- and VIP-immunoreactive nerve fibers were visualized by immunofluorescence microscopy and subjected to quantitative scoring, and the number of mast cells per unit area was counted. The results were compared to the histological findings and the clinical status. Lamina propria contained fibers showing bright immunofluorescence for SP and VIP. The mean fluorescence intensity score of SP-immunoreactive nerve fibers in the lamina propria remained similar after the follow-up period (2.99 +/- 0.79 and 2.06 +/- 0.82, NS). SP-immunoreactive innervation correlated with the grade of acute (R2 = 0.5396, P = 0.0242) and chronic inflammation (R2 = 0.4561, P = 0.0459), while SP and VIP immunoreactivity, mast cell count, and histological changes did not correlate with the clinical status. The present study demonstrates an increase in the density of SP-immunoreactive nerve fibers in inflamed ileal pouch mucosa of clinically asymptomatic pouchitis patients. These results raise the possibility of therapeutic interference of SP-related processes in treatment of pouchitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769299     DOI: 10.1007/bf02087922

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

1.  Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens.

Authors:  N A Shepherd; J R Jass; I Duval; R L Moskowitz; R J Nicholls; B C Morson
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

2.  Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes.

Authors:  W A Kmiot; S R Hesslewood; N Smith; H Thompson; L K Harding; M R Keighley
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

3.  Histologic and microbiologic features of biopsy samples from patients with normal and inflamed pouches.

Authors:  R S McLeod; D Antonioli; J Cullen; A Dvorak; A Onderdonk; W Silen; J E Blair; R Monahan-Earley; R Cisneros; Z Cohen
Journal:  Dis Colon Rectum       Date:  1994-01       Impact factor: 4.585

4.  Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel.

Authors:  G L Ferri; T E Adrian; M A Ghatei; D J O'Shaughnessy; L Probert; Y C Lee; A M Buchan; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

5.  Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.

Authors:  T King; W Biddle; P Bhatia; J Moore; P B Miner
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

6.  Histamine release from gut mast cells from patients with inflammatory bowel diseases.

Authors:  H Nolte; N Spjeldnaes; A Kruse; B Windelborg
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

7.  Ion transport abnormalities in inflamed rat jejunum. Involvement of mast cells and nerves.

Authors:  M H Perdue; J Marshall; S Masson
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

8.  Mucosal characteristics of pelvic ileal pouches.

Authors:  H J de Silva; P R Millard; M Kettlewell; N J Mortensen; C Prince; D P Jewell
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

9.  Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: evidence for regulation of vasoactive intestinal peptide release by nitric oxide.

Authors:  J R Grider; J G Jin
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

10.  Treatment of the mucosa with local anaesthetics in ulcerative colitis.

Authors:  S Björck; A Dahlström; L Johansson; H Ahlman
Journal:  Agents Actions       Date:  1992
View more
  6 in total

1.  Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.

Authors:  Maria Jönsson; Orjan Norrgård; Sture Forsgren
Journal:  Dig Dis Sci       Date:  2011-12-06       Impact factor: 3.199

2.  Reduced neurons in the ileum of proctocolectomized rat models.

Authors:  Chun-Mei Zhao; Helge E Myrvold; Duan Chen
Journal:  Med Mol Morphol       Date:  2014-11-29       Impact factor: 2.309

Review 3.  The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.

Authors:  Miguel Munoz; Rafael Covenas; Francisco Esteban; Maximino Redondo
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

Review 4.  Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Authors:  Amosy E M'Koma; Paul E Wise; Roberta L Muldoon; David A Schwartz; Mary K Washington; Alan J Herline
Journal:  Int J Colorectal Dis       Date:  2007-06-19       Impact factor: 2.571

Review 5.  The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer.

Authors:  Marisa Rosso; Miguel Muñoz; Michael Berger
Journal:  ScientificWorldJournal       Date:  2012-04-01

Review 6.  Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature.

Authors:  Francisco Esteban; Pablo Ramos-García; Miguel Muñoz; Miguel Ángel González-Moles
Journal:  Int J Environ Res Public Health       Date:  2021-12-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.